EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States

Tetsuya Tajima iD, Olivia M Martinez, Daniel Bernstein, Scott D Boyd, Dita Gratzinger iD, Grant Lum, Kazunari Sasaki, Brent Tan, Clare J Twist, Kenneth Weinberg, Brian Armstrong, Dev M Desai und 7 weitere

Pediatric Transplantation · 2024-06 · 28 (4)

DOI: 10.1111/petr.14763 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Transplantation, online erschienen am 29.04.2024. Verfasst von Tetsuya Tajima und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Abdominal Transplantation, Department of Surgery, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Lymphoproliferative Disorders, Epstein-Barr Virus Infections, Organ Transplantation, Postoperative Complications. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, The Transplant and Tissue Engineering Center at Stanford Children's, National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epstein–Barr virus (EBV)‐associated post‐transplant lymphoproliferative disorders (PTLD) is the most common malignancy in children after transplant; however, difficulties for early detection may worsen the prognosis.

Methods

The prospective, multicenter, study enrolled 944 children (≤21 years of age). Of these, 872 received liver, heart, kidney, intestinal, or multivisceral transplants in seven US centers between 2014 and 2019 (NCT02182986). In total, 34 pediatric EBV+ PTLD (3.9%) were identified by biopsy. Variables included sex, age, race, ethnicity, transplanted organ, EBV viral load, pre‐transplant EBV serology, immunosuppression, response to chemotherapy and rituximab, and histopathological diagnosis.

Results

The uni−/multivariable competing risk analyses revealed the combination of EBV‐seropositive donor and EBV‐naïve recipient (D+R−) was a significant risk factor for PTLD development (sub‐hazard ratio: 2.79 [1.34–5.78], p = .006) and EBV DNAemia (2.65 [1.72–4.09], p < .001). Patients with D+R− were significantly more associated with monomorphic/polymorphic PTLD than those with the other combinations ( p = .02). Patients with monomorphic/polymorphic PTLD ( n = 21) had significantly more EBV DNAemia than non‐PTLD patients ( p < .001) and an earlier clinical presentation of PTLD than patients with hyperplasias ( p < .001), within 6‐month post‐transplant. Among non‐liver transplant recipients, monomorphic/polymorphic PTLD were significantly more frequent than hyperplasias in patients ≥5 years of age at transplant ( p = .01).

Conclusions

D+R− is a risk factor for PTLD and EBV DNAemia and associated with the incidence of monomorphic/polymorphic PTLD. Intensive follow‐up of EBV viral load within 6‐month post‐transplant, especially for patients with D+R− and/or non‐liver transplant recipients ≥5 years of age at transplant, may help detect monomorphic/polymorphic PTLD early in pediatric transplant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoproliferative DisordersEpstein-Barr Virus InfectionsOrgan TransplantationPostoperative ComplicationsHumansMaleProspective StudiesChildFemaleUnited StatesChild, PreschoolAdolescentInfantRisk FactorsHerpesvirus 4, HumanYoung Adult

Stichwörter der Autor:innen

Epstein–Barr virusPTLDpediatric transplantation

Autor:innen und Institutionen

  • Division of Abdominal Transplantation, Department of Surgery, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Rho Federal Systems Division, Rho, Durham, North Carolina, USA.
  • Division of Surgical Transplantation, University of Texas (UT) Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Tetsuya Tajima, Dita Gratzinger, George V Mazariegos, Robert S Venick

Förderung

  • NIAID NIH HHS
  • The Transplant and Tissue Engineering Center at Stanford Children's
  • National Institute of Allergy and Infectious Diseases of the National Institutes of Health
  • Rho Federal Systems
  • National Institutes of Health

Zitieren

APA

Tajima, T., Martinez, O. M., Bernstein, D., Boyd, S. D., Gratzinger, D., Lum, G., Sasaki, K., Tan, B., Twist, C. J., Weinberg, K., Armstrong, B., Desai, D. M., Mazariegos, G. V., Chin, C., Fishbein, T. M., Tekin, A., Venick, R. S., Krams, S. M., & Esquivel, C. O. (2024). Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States. Pediatric Transplantation, 28(4). https://doi.org/10.1111/petr.14763

Vancouver

Tajima T, Martinez OM, Bernstein D, Boyd SD, Gratzinger D, Lum G, et al. Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States. Pediatric Transplantation. 2024;28(4). doi:10.1111/petr.14763

BibTeX
@article{Tajima2024,
  author = {Tajima, Tetsuya and Martinez, Olivia M and Bernstein, Daniel and Boyd, Scott D and Gratzinger, Dita and Lum, Grant and Sasaki, Kazunari and Tan, Brent and Twist, Clare J and Weinberg, Kenneth and Armstrong, Brian and Desai, Dev M and Mazariegos, George V and Chin, Clifford and Fishbein, Thomas M and Tekin, Akin and Venick, Robert S and Krams, Sheri M and Esquivel, Carlos O},
  title = {Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States},
  journal = {Pediatric Transplantation},
  year = {2024},
  volume = {28},
  number = {4},
  doi = {10.1111/petr.14763}
}
Kostenlos starten →